1. Home
  2. ADMA vs NEA Comparison

ADMA vs NEA Comparison

Compare ADMA & NEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$20.16

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Logo Nuveen AMT-Free Quality Municipal Income Fund of Beneficial Interest Par Value $.01

NEA

Nuveen AMT-Free Quality Municipal Income Fund of Beneficial Interest Par Value $.01

HOLD

Current Price

$11.65

Market Cap

3.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADMA
NEA
Founded
2004
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ADMA
NEA
Price
$20.16
$11.65
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$28.50
N/A
AVG Volume (30 Days)
3.7M
803.4K
Earning Date
11-05-2025
01-01-0001
Dividend Yield
N/A
4.23%
EPS Growth
205.35
N/A
EPS
0.86
N/A
Revenue
$488,559,000.00
N/A
Revenue This Year
$21.08
N/A
Revenue Next Year
$25.98
N/A
P/E Ratio
$23.56
N/A
Revenue Growth
27.63
N/A
52 Week Low
$13.50
$9.20
52 Week High
$25.67
$11.37

Technical Indicators

Market Signals
Indicator
ADMA
NEA
Relative Strength Index (RSI) 76.50 59.93
Support Level $18.73 $11.44
Resistance Level $19.48 $11.57
Average True Range (ATR) 0.74 0.09
MACD 0.33 0.00
Stochastic Oscillator 98.00 95.59

Price Performance

Historical Comparison
ADMA
NEA

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About NEA Nuveen AMT-Free Quality Municipal Income Fund of Beneficial Interest Par Value $.01

Nuveen AMT-Free Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax and the alternative minimum tax applicable to individuals, by investing in an actively managed portfolio of tax-exempt municipal securities. The company invest in Transportation, Utilities, Healthcare, Education and Civics, and other sectors, with maximum investment in Transportation.

Share on Social Networks: